NCT07094516View on ClinicalTrials.gov

A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

407

Participants

Timeline

Start Date

September 18, 2025

Primary Completion Date

September 14, 2028

Study Completion Date

December 31, 2030

Conditions
Alzheimer's Disease
Interventions
BIOLOGICAL

VHB937

VHB937 solution for infusion

BIOLOGICAL

VHB937

VHB937 solution for infusion

OTHER

Placebo

Solution for infusion

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY